Search research articles
Contact Us
Filters
Showing results (61-70 of 81) with videos related to
Page
of 9
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile
A J Coyle, S Tsuyuki, C Bertrand, et al.
Biochimica Et Biophysica Acta
|
December 17, 1987
The effect of ethylenediamine chemical modification of plastocyanin on the rate of cytochrome f oxidation and P-700+ reduction
G P Anderson, D G Sanderson, C H Lee, et al.
The Journal of Clinical Investigation
|
December 1, 1995
Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways
S Tsuyuki, C Bertrand, F Erard, et al.
Science (New York, N.Y.)
|
February 23, 1973
Mariner 9 ultraviolet spectrometer experiment: seasonal variation of ozone on Mars
C A Barth, C W Hord, A I Stewart, et al.
Biosensors & Bioelectronics
|
April 2, 1999
Detecting staphylococcal enterotoxin B using an automated fiber optic biosensor
K D King, G P Anderson, K E Bullock, et al.
Journal of Molecular Recognition : JMR
|
December 13, 2000
Phage-displayed peptides as biosensor reagents
E R Goldman, M P Pazirandeh, J M Mauro, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 1, 1995
Interleukin-4 is required for the induction of lung Th2 mucosal immunity
A J Coyle, G Le Gros, C Bertrand, et al.
Archives of Biochemistry and Biophysics
|
February 15, 1985
Conformational changes in plastocyanin
J E Draheim, G P Anderson, R L Pan, et al.
Journal of Lipid Mediators
|
March 1, 1993
Strategies in the design of peptidoleukotriene antagonists
A von Sprecher, A Beck, M Gerspacher, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist
M Gerspacher, A von Sprecher, R Mah, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 81) with videos related to
Sort By:
Page
of 9
Journal of Immunology (Baltimore, Md. : 1950)
|
April 15, 1996
Mice lacking the IFN-gamma receptor have impaired ability to resolve a lung eosinophilic inflammatory response associated with a prolonged capacity of T cells to exhibit a Th2 cytokine profile
A J Coyle, S Tsuyuki, C Bertrand, et al.
Biochimica Et Biophysica Acta
|
December 17, 1987
The effect of ethylenediamine chemical modification of plastocyanin on the rate of cytochrome f oxidation and P-700+ reduction
G P Anderson, D G Sanderson, C H Lee, et al.
The Journal of Clinical Investigation
|
December 1, 1995
Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways
S Tsuyuki, C Bertrand, F Erard, et al.
Science (New York, N.Y.)
|
February 23, 1973
Mariner 9 ultraviolet spectrometer experiment: seasonal variation of ozone on Mars
C A Barth, C W Hord, A I Stewart, et al.
Biosensors & Bioelectronics
|
April 2, 1999
Detecting staphylococcal enterotoxin B using an automated fiber optic biosensor
K D King, G P Anderson, K E Bullock, et al.
Journal of Molecular Recognition : JMR
|
December 13, 2000
Phage-displayed peptides as biosensor reagents
E R Goldman, M P Pazirandeh, J M Mauro, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 1, 1995
Interleukin-4 is required for the induction of lung Th2 mucosal immunity
A J Coyle, G Le Gros, C Bertrand, et al.
Archives of Biochemistry and Biophysics
|
February 15, 1985
Conformational changes in plastocyanin
J E Draheim, G P Anderson, R L Pan, et al.
Journal of Lipid Mediators
|
March 1, 1993
Strategies in the design of peptidoleukotriene antagonists
A von Sprecher, A Beck, M Gerspacher, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 11, 2000
N-[(R,R)-(E)-1-(4-chloro-benzyl)-3-(2-oxo-azepan-3-ylcarbamoyl)-allyl]-N-methyl-3,5-bis-trifluoromethyl-benzamide: an orally active neurokinin NK1/NK2 antagonist
M Gerspacher, A von Sprecher, R Mah, et al.
Page
of 9